NYSE:IMS

IMS Health (IMS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$31.34
$31.34
50-Day Range
N/A
52-Week Range
$22.36
$31.59
Volume
N/A
Average Volume
1.27 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
IMS stock logo

About IMS Health Stock (NYSE:IMS)

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.

IMS Stock News Headlines

“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
Axxela gets ISO recertification
Rev 2024 announces entertainment lineup
See More Headlines
Receive IMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMS Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/27/2016
Today
4/26/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

IMS Stock Analysis - Frequently Asked Questions

How were IMS Health's earnings last quarter?

IMS Health Holdings Inc (NYSE:IMS) announced its earnings results on Wednesday, July, 27th. The information technology services provider reported $0.41 EPS for the quarter, topping the consensus estimate of $0.38 by $0.03. The information technology services provider earned $802 million during the quarter, compared to analyst estimates of $796.93 million. The business's quarterly revenue was up 112.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.37 earnings per share.

What other stocks do shareholders of IMS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMS Health investors own include Frontier Communications (FTR), Cognizant Technology Solutions (CTSH), Dollar Tree (DLTR), Oxford Immunotec Global (OXFD), Exact Sciences (EXAS), Ford Motor (F), Hertz Global (HTZ), Incyte (INCY), IQVIA (IQV) and

This page (NYSE:IMS) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners